Contraception

• FDA approval · 2011-05-18
  FDA Approved: INTROVALE — Supplemental Application (Xiromed, LLC.)

  FDA approved a supplemental application for INTROVALE (levonorgestrel and ethinyl estradiol) from Xiromed, LLC., for this combined oral cont…

• FDA approval · 2011-03-28
  FDA Approved: LORYNA — Original Application (Xiromed, LLC.)

  FDA approved LORYNA as an Original Application for a generic drospirenone and ethinyl estradiol tablet by Xiromed, LLC.

• FDA approval · 2010-10-15
  FDA Approved: MEDROXYPROGESTERONE ACETATE — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application for Medroxyprogesterone Acetate submitted by Prasco Laboratories.

• FDA approval · 2010-07-22
  FDA Approved: NORETHINDRONE — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's original ANDA for norethindrone tablets, a progestin used as a generic contraceptive.

• FDA approval · 2009-11-06
  FDA Approved: JINTELI — Original Application (Teva Pharmaceuticals USA, Inc.)

  FDA approves JINTELI as an original generic application for a norethindrone acetate and ethinyl estradiol contraceptive, submitted by Teva P…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2009-10-01
  FDA Approved: MIRENA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  The FDA granted approval for a supplemental application for MIRENA (levonorgestrel intrauterine system) submitted by Bayer HealthCare Pharma…

• FDA approval · 2008-10-24
  FDA Approved: CAMRESE LO — Original Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved Camrese Lo under an original application; it is a combined oral contraceptive containing levonorgestrel and ethinyl estradiol.

• FDA approval · 2008-07-21
  FDA Approved: MIRENA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved a supplemental application for MIRENA (levonorgestrel) submitted by Bayer HealthCare Pharmaceuticals Inc. The action is a suppl…

• FDA approval · 2007-01-26
  FDA Approved: YAZ — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

  FDA approved Bayer’s supplemental application for YAZ (drospirenone and ethinyl estradiol), authorizing updates to the product labeling.

• FDA approval · 2006-05-25
  FDA Approved: CAMRESE — Original Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved CAMRESE, an oral contraceptive, under an Original Application submitted by Teva Pharmaceuticals USA, Inc. The product conta…